The slashing of over half of SA’s HIV and TB projects funded by the US government will affect more than HIV testing and HIV prevention and treatment drugs. The diagnoses and treatment of ...

Nigeria will need N2.2 trillion for cervical cancer interventions by 2030, ... Nigeria needs N1.42tn for cervical cancer treatment by 2030 – ex-Minister . 3rd June 2025 ...

With the approval for first-line cervical cancer, cadonilimab has achieved comprehensive coverage for the treatment of advanced cervical cancer, offering an innovative treatment option for patients ...

With the approval for first-line cervical cancer, cadonilimab has achieved comprehensive coverage for the treatment of advanced cervical cancer, offering an innovative treatment option for ...

This is because of the low rate of those affected and because it can lead to unnecessary treatment. Cancer Research UK data shows that while some cases of cervical cancer are diagnosed in people who ...

Akeso's PD-1/CTLA-4 Bispecific Antibody Cadonilimab Approved for First-Line Treatment of Cervical Cancer in All-Comer Populations--Third Approved Indication for Cadonilimab.

Akeso, Inc. (9926.HK)The approval for cadonilimab's use in combination with chemotherapy (with or without bevacizumab) in first-line cervical cancer is based on the clinical data from the Phase ...

(RTTNews) - Akeso Inc. announced that the National Medical Products Administration (NMPA) has approved the company's first- in-class PD-1/CTLA-4 bispecific antibody, cadonilimab, for the first ...

As per the data gathered from the 13 govt hospitals, 1,164 women were tested positive for cervical cancer in the district in 2024-25, against 726 in 2023-34 and 484 in 2022-23.

As government clinics take on HIV patients who were previously treated by Pepfar-funded projects, the treatment of conditions like diabetes and heart disease will come under pressure ...